The Prescription Drug Monitoring Program Training and Technical Assistance Center (PDMP TTAC) reports 2020 data and 2021 features of the Washington state Prescription Drug Monitoring Program (PDMP).
The name of the Washington PDMP is Prescription Review. It is administered by the Washington State Department of Health. The email address is provided, along with the URLs of the main website and related websites for registering, query, statistics, opioid dashboard, training, statute/regulation, and opioid guidelines. Contact information is provided for the Drug Systems Director and the PMP Program Manager. In 2020, the state population was 7,715,946, and there were 48,821 DEA-registered prescribers and 1,289 DEA-registered dispensers. Eight transmitters of data to the PDMP are listed. Substances monitored are drugs of concern and those listed on Schedules II-V. Data are also collected on ARCOS Reports, fatal overdoses, and pharmaceutical manufacturers/distributors. Sixteen types of reports available from the PDMP are listed, along with 15 PDMP statistical capabilities. There are 39 types of authorized PDMP users from the domains of correctional supervision, law enforcement, prosecutors, dispensers, prescribers, healthcare, patients, regulatory bodies, researchers, state health departments, and workers compensation. There are 33 types of engaged PDMP users from these domains. The PDMP budget for 2021 is $4,500,000, with funding from a CDC grant. There are eight staff members, with five engaged in operational tasks and three performing analytical tasks. Technologies and provider sources are listed. Types of PDMP patient matching and the information required are reported. Interstate data sharing partners are listed. Significant dates in the establishment and development of the PDMP are provided. Features and mandates of PDMP enrollment and accounts are reported. Procedures for unsolicited reports/push notifications are indicated
810 Seventh Street NW, Washington, DC 20531, United States